2 results
Approved WMOCompleted
Primary:* To determine the efficacy profile of PA101 delivered via a high efficiency nebulizer (eFlow®,PARI) in comparison with placebo following 6 weeks of treatment in patients with indolentsystemic mastocytosis (ISM) who are symptomatic despite…
Approved WMOCompleted
The objective of the study is to assess the safety and efficacy of the R-One device in elective Percutaneous Coronary intervention.